Donna Hanrahan Gambaccini retweeted
Keeping light at end of #valuebasedcare tunnel in mind can help with pain of implementation. Whether means right yet or not, better #patient care is goal. https://teapawt.org/t.co/d0oTQR09Eb
#FDA issues “leap-frog” guidance on #3Dprinting of #medical product to bridge where we are today with #innovations of tomorrow fda.gov/downloads/MedicalDev… #pharma #meddevice
1
1
Donna Hanrahan Gambaccini retweeted
Many reasons & thoughts why #healthcare #CyberSecurity lags. Time to "Just Do It" as Nike says. https://teapawt.org/t.co/smKiF85m9n #IoMTchat #HIPAA
Donna Hanrahan Gambaccini retweeted
74% of meds in dev have potential to be first of kind – new ways of treating disease. More in new report: onphr.ma/2uEJrBI #GoBoldly
Our latest article: How the #CuresAct is changing #FDA pathways and processes for #drugs & #devices. lifescienceleader.com/doc/dr… @LowensteinLLP
Donna Hanrahan Gambaccini retweeted
In @Westlaw #pharma, attys @jimmyshehan Tara D'Orsi & @EthicalLens review changes made by the 21st Century Cures Act https://teapawt.org/t.co/srLhclLWhO
Donna Hanrahan Gambaccini retweeted
Medical device enforcement is getting more serious—particularly in Northeast ift.tt/2miVH2s #meddevice
Sparking Discussion & Fueling the Fire-#FDA Discussion Paper on LDTs https://teapawt.org/t.co/wF36oe6ggG #pharma #healthlaw #biotech #dna @LowensteinLLP
I'm in! Looking forward to it @jmorelnyc !
Life Science Industry: 2016 and 2017 in Review Webinar 2/16 2PM EST ow.ly/VnEi308OwaN teapawt.org/BerkleyLifeSci/status/…
Register @BerkleyLifeSci @BowmandBrooke webinar "Life Science Industry: 2016 and 2017 in Review" Feb 16 2PM (EST) ow.ly/VnEi308OwaN
1
#Diversity is a fact; #Inclusion is a choice-Celebrating Diversity in Compliance @SetonHallLaw w/ @JNJCares @PorzioLS @AstraZeneca @PSEGNews
1/3 Americans Don’t Know #Obamacare and the #ACA Are the Same
nytimes.com/2017/02/07/upsho… #bioethics #publichealth #healthcare #healthpolicy
2
#publichealthlaw #bioethics #healthlaw #FDA #pharma #research #compliance #healthcare #antibiotics #Rx #innovation teapawt.org/EthicalLens/status/828…
Combating Resistance: Fed Efforts to Curb Misuse & Incentivize Development of #Antibiotic Drugs https://teapawt.org/t.co/kas6wq6F3m #publichealth #law
Combating Resistance: Fed Efforts to Curb Misuse & Incentivize Development of #Antibiotic Drugs https://teapawt.org/t.co/kas6wq6F3m #publichealth #law
With a Whisper, Not a Shout, #FDA Breaks Silence on #Medical Product #Communications https://teapawt.org/t.co/FZruOdlwqY #pharma #marketing #rx #device
With a Whisper, Not a Shout, #FDA Breaks Silence on Medical Product Communications https://teapawt.org/t.co/FZruOdlwqY #pharma #meddevice #marketing
#FDA released draft guidance on Medical Product Communications Consistent w/ FDA-Required Labeling protect-us.mimecast.com/s/Zp… #offlabel #pharma
#HumanSubject #research protection enhanced, oversight system modernized in #HHS Final Rule hhs.gov/about/news/2017/01/1… #commonrule #bioethics
#FDA issues draft guidance on #Drug and #Device Manufacturer Communications w/ Payors, Formulary Committees, etc. protect-us.mimecast.com/s/LL…
Repeal of the #ACA just moved a step closer to reality - House passes budget resolution. #healthlaw teapawt.org/TheAtlantic/status/820…
Repeal of the Affordable Care Act just moved a step closer to reality theatln.tc/2j95OGF











